Improved therapeutic protocols

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/36 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2458856

The present invention relates to the field of chemotherapy of diseases such as cell proliferation disorders including cancer. In particular, the present invention relates to the use of hyaluronan (HA) as a protective agent in the treatment of subjects. HA is administered in conjunction with a chemotherapeutic agent to facilitate the prolonged administration of a dose of the chemotherapeutic agent to be administered to a subject. Owing to the protective effects of the HA, the dose of chemotherapeutic agent may be substantially higher than a generally accepted effective dose, which would otherwise be expected to cause unacceptable side effects in the subject.

La présente invention concerne le domaine de la chimiothérapie de maladies telles que les troubles de la prolifération cellulaire, y compris le cancer. L'invention concerne en particulier l'utilisation d'hyaluronan (HA) comme agent protecteur dans le traitement des patients. Le HA est administré conjointement à un agent chimiothérapeutique afin de faciliter l'administration prolongée d'une dose de l'agent chimiothérapeutique à administrer au patient. En raison des effets protecteurs du HA, la dose de l'agent chimiothérapeutique peut être sensiblement supérieure à une dose efficace généralement acceptée, mais serait autrement considérée susceptible de générer des effets secondaires inacceptables chez le patient.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Improved therapeutic protocols does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved therapeutic protocols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved therapeutic protocols will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1645056

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.